Codexis, Inc.
NASDAQ:CDXS
3.19 (USD) • At close October 29, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Codexis, Inc. |
Symbool | CDXS |
Munteenheid | USD |
Prijs | 3.19 |
Beurswaarde | 226,258,406 |
Dividendpercentage | 0% |
52-weken bereik | 1.51 - 4.91 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Stephen George Dilly MBBS, Ph.D. |
Website | https://www.codexis.com |
An error occurred while fetching data.
Over Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)